Published in Am J Hematol on March 01, 1988
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A (1989) 2.45
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10
Ethical aspects of banking placental blood for transplantation. JAMA (1995) 2.07
Successful therapy for trilateral retinoblastoma. Am J Ophthalmol (1992) 2.03
Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr (1996) 1.84
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med (1987) 1.75
Bacteremia in sickle hemoglobinopathies. J Pediatr (1986) 1.69
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med (1988) 1.62
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol (1993) 1.61
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Establishment of the DU.528 human lymphohemopoietic stem cell line. J Exp Med (1985) 1.56
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study. Am J Clin Pathol (1991) 1.52
Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst (1982) 1.52
Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells (1991) 1.50
Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med (1998) 1.47
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant (2002) 1.44
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci U S A (1990) 1.43
Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol (2001) 1.43
Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr (1997) 1.42
Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today (1989) 1.41
Cancer in children of parents exposed to hydrocarbon-related industries and occupations. Am J Epidemiol (1980) 1.38
T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant (2001) 1.33
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol (1988) 1.23
Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology (2001) 1.23
Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease. AJNR Am J Neuroradiol (2009) 1.18
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol (1996) 1.18
Severe Mycoplasma pneumonia in three sisters with sickle cell disease. Pediatr Hematol Oncol (1986) 1.16
Risk factors for Wilms tumor. Report from the National Wilms Tumor Study. Cancer (1993) 1.14
Childhood cancer and occupational radiation exposure in parents. Cancer (1984) 1.14
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol (1997) 1.14
Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency. J Clin Invest (1990) 1.12
Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood. Cytotherapy (2007) 1.10
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1990) 1.08
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant (2001) 1.08
Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant (2008) 1.07
Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature. J Neurooncol (1998) 1.07
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. J Clin Oncol (1998) 1.06
Human thymic epithelial cells directly induce activation of autologous immature thymocytes. Proc Natl Acad Sci U S A (1988) 1.06
Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning (1990) 1.05
Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplant (2013) 1.04
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies. J Clin Oncol (2000) 1.02
Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant (2007) 1.02
Experience with minimal complications in implanted catheters in children. Am J Pediatr Hematol Oncol (1989) 1.00
The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring. Clin Epigenetics (2011) 1.00
Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation. Proc Natl Acad Sci U S A (1986) 0.99
Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors. J Immunol (1988) 0.98
Wilms' tumor and paternal occupation. Cancer Res (1990) 0.98
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study). Blood (1982) 0.96
Human postnatal CD4- CD8- CD3- thymic T cell precursors differentiate in vitro into T cell receptor delta-bearing cells. J Immunol (1989) 0.95
Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy. Am J Pediatr Hematol Oncol (1992) 0.95
Rescuing the neonatal brain from hypoxic injury with autologous cord blood. Bone Marrow Transplant (2012) 0.93
Transumbilical balloon coarctation angioplasty in neonates with critical aortic coarctation. Am Heart J (1992) 0.93
Chronic immune-mediated thrombocytopenia after varicella infection. J Pediatr (1988) 0.93
Murine cytomegalovirus infection: hematological, morphological, and functional study of lymphoid cells. Infect Immun (1981) 0.92
Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Cancer Res (1985) 0.92
Detection and partial characterization of human thymus-leukemia antigens. J Natl Cancer Inst (1980) 0.92
Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant (2009) 0.91
Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation. J Hematother (1996) 0.90
Lipoid pneumonia in an adolescent girl secondary to use of lip gloss. J Pediatr (1984) 0.90
Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol (1995) 0.89
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery (1986) 0.89
Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol (1992) 0.88
Infectious and bleeding complications in patients with glycogenosis Ib. Am J Dis Child (1985) 0.88
An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer (1995) 0.87
A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Am J Hosp Pharm (1974) 0.87
Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol (1994) 0.87
Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Exp Hematol (1998) 0.87
The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. Exp Hematol (1994) 0.86
Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy (2008) 0.86
Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function. Clin Exp Immunol (1987) 0.85
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity. Br J Cancer (1999) 0.85
Association of reticular dysgenesis (thymic alymphoplasia and congenital aleukocytosis) with bilateral sensorineural deafness. J Pediatr (1999) 0.84
CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study. Cancer (1982) 0.84
Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study. Cancer Treat Rep (1979) 0.84
Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol (1993) 0.83
The fetal alcohol syndrome and neuroblastoma. Pediatrics (1980) 0.83
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med Pediatr Oncol (1998) 0.83
Childhood hepatic mesenchymoma: successful treatment with surgery and multiple-agent chemotherapy. Med Pediatr Oncol (1988) 0.83
Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. Exp Eye Res (1992) 0.82
Differences in chromatin proteins of resting and growing human lymphocytes. Exp Cell Res (1976) 0.82
Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. Leukemia (1993) 0.82